Table 2.
Clinicopathologic characteristics of HCC patients
| Characteristics | Median (range) or N/% |
|---|---|
| Age/years, median (range) | 61(17-90) |
| Age group/n (%) | |
| < 60 years | 169 (45.3%) |
| ≥ 60 years | 204(54.7%) |
| Gender/n (%) | |
| Male | 252 (67.4%) |
| Female | 122 (32.6%) |
| Race/n (%) | |
| White | 182 (50.0%) |
| Asian | 161 (44.2%) |
| Black | 19 (5.2%) |
| American Indian | 2 (0.6%) |
| G stage/n (%) | |
| G1 | 55 (14.9%) |
| G2 | 178 (48.2%) |
| G3 | 124 (33.6%) |
| G4 | 12 (3.3%) |
| TNM stage/n (%) | |
| I | 173 (49.0%) |
| II | 88 (24.9%) |
| III | 86 (24.4%) |
| IV | 6 (1.7%) |
| T stage/n (%) | |
| T1 | 182 (49.1%) |
| T2 | 95 (25.6%) |
| T3 | 81 (21.8%) |
| T4 | 13 (3.5%) |
| Vascular invasion/n (%) | |
| Macrovascular invasion | 16 (5.0%) |
| Microvascular invasion | 94 (29.6%) |
| None | 208 (65.4%) |
HCC, hepatocellular carcinoma. The case numbers of clinicopathologic characteristics are not available, which including 1 for age, 10 for race, 5 for G stage, 21 for TNM stage, 3 for T stage, and 56 for vascular invasion.